{
    "clinical_study": {
        "@rank": "30147", 
        "arm_group": {
            "arm_group_label": "Adapalene/BPO Gel/Foam Wash/Moisturizer", 
            "arm_group_type": "Experimental", 
            "description": "Adapalene BPO Gel Pump (once daily) in conjunction with a Foam Wash (twice daily) and Moisturizer SPF 30 (once daily)"
        }, 
        "brief_summary": {
            "textblock": "This is an open-label, multi-center study to be conducted in the United States. The study\n      will examine the change in lesion count in subjects using Epiduo\u00ae Gel Pump (once daily) in\n      conjunction with Cetaphil\u00ae DermaControl\u2122  Foam Wash (twice daily) and Moisturizer SPF 30\n      (once daily). Subjects with a clinical diagnosis of mild or moderate acne who are eligible\n      for treatment with Epiduo\u00ae in accordance with the currently approved product labeling and\n      who meet other inclusion/exclusion criteria are to be enrolled in the study and receive the\n      study products for 8 weeks. Efficacy and safety assessments include: complete lesion counts,\n      cutaneous irritation assessment, end of study treatment questionnaire, photographic\n      evaluation for oiliness, skin tone, and P Acnes, hydration assessment, barrier function\n      assessment, treatment compliance, and adverse event assessment."
        }, 
        "brief_title": "Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Acne", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Men and women of any race, 9 years or older, with a diagnosis of mild to moderate acne,\n        who are eligible for treatment with adapalene BPO gel in accordance with the currently\n        approved product labeling.\n\n        Exclusion Criteria:\n\n        - Subjects with nodules and cysts, pregnant or breastfeeding, with any systemic or\n        dermatological disorder, or topical condition or facial hair that could interfere with\n        evaluations."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "9 Years"
        }, 
        "enrollment": {
            "#text": "81", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01951417", 
            "org_study_id": "GLI.04.SRE.04.US10268"
        }, 
        "intervention": [
            {
                "arm_group_label": "Adapalene/BPO Gel/Foam Wash/Moisturizer", 
                "description": "Adapalene/Benzoyl Peroxide (BPO) Gel Pump (once daily)", 
                "intervention_name": "Adapalene/BPO Gel", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Epiduo\u00ae (adapalene and benzoyl peroxide) Gel 0.1%/2.5% Pump", 
                    "Adapalene and benzoyl peroxide (BPO) gel"
                ]
            }, 
            {
                "arm_group_label": "Adapalene/BPO Gel/Foam Wash/Moisturizer", 
                "description": "Moisturizer SPF 30 (once daily)", 
                "intervention_name": "Moisturizer SPF 30", 
                "intervention_type": "Other", 
                "other_name": "Cetaphil\u00ae DermaControl\u2122  Moisturizer SPF 30"
            }, 
            {
                "arm_group_label": "Adapalene/BPO Gel/Foam Wash/Moisturizer", 
                "description": "Foam Wash (twice daily)", 
                "intervention_name": "Foam Wash", 
                "intervention_type": "Other", 
                "other_name": "Cetaphil\u00ae DermaControl\u2122  Foam Wash"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Adapalene", 
                "Benzoyl Peroxide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Boynton Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33437"
                    }, 
                    "name": "Study Protocol, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37215"
                    }, 
                    "name": "Tennessee Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carrolton", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75006"
                    }, 
                    "name": "Stephens & Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "College Station", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77845"
                    }, 
                    "name": "J&S Studies, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antoinio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "The Dermatology Clinical Research Center of San Antonio"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Epiduo\u00ae (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump Cetaphil\u00ae DermaControl\u2122 Moisturizer SPF 30, and Cetaphil\u00ae DermaControl\u2122 Foaming Wash Regimen in Patients With Mild to Moderate Acne Vulgaris", 
        "other_outcome": [
            {
                "description": "Adverse events experienced during use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "Cutaneous irritability assessments (stinging/burning, erythema, scaling, dryness) experienced during use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Stinging/Burning", 
                "safety_issue": "Yes", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "Cutaneous irritability assessments (stinging/burning, erythema, scaling, dryness) experienced during use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Erythema", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Cutaneous irritability assessments (stinging/burning, erythema, scaling, dryness) experienced during use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Scaling", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Cutaneous irritability assessments (stinging/burning, erythema, scaling, dryness) experienced during use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Dryness", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Dermatology Associates, PA, of the Palm Beaches", 
            "last_name": "Joshua M Berlin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The change in total lesion count after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks.", 
            "measure": "Total Lesion Count", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01951417"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The change in oiliness after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks", 
                "measure": "Oiliness", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in the skin tone after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks", 
                "measure": "Skin tone", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in the P acnes after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks", 
                "measure": "P acnes", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in inflammatory lesions after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks.", 
                "measure": "Inflammatory lesions", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in non-inflammatory lesions after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks", 
                "measure": "Non-inflammatory lesions", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in skin hydration after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks.", 
                "measure": "Skin hydration", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "The change in barrier function after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 2 weeks, 4 weeks, and 8 weeks.", 
                "measure": "Barrier function", 
                "safety_issue": "No", 
                "time_frame": "8 Weeks"
            }, 
            {
                "description": "Describe subject satisfaction after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Subject questionnaire", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Describe investigator satisfaction after use of adapalene BPO gel in conjunction with Foam Wash and Moisturizer SPF 30 for 8 weeks.", 
                "measure": "Investigator questionnaire", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Galderma Laboratories, L.P.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galderma Laboratories, L.P.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}